The new oral antifungal drugs in the treatment of the yellow nail syndrome
Identifieur interne : 002093 ( Istex/Corpus ); précédent : 002092; suivant : 002094The new oral antifungal drugs in the treatment of the yellow nail syndrome
Auteurs : R. BaranSource :
- British Journal of Dermatology [ 0007-0963 ] ; 2002-07.
Url:
DOI: 10.1046/j.1365-2133.2002.48119.x
Links to Exploration step
ISTEX:47C5023827ABEF3A924BDE23BB2C4163CB89E9F0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
<author><name sortKey="Baran, R" sort="Baran, R" uniqKey="Baran R" first="R." last="Baran">R. Baran</name>
<affiliation><mods:affiliation>Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: baran.r@club‐internet.fr</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:47C5023827ABEF3A924BDE23BB2C4163CB89E9F0</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1046/j.1365-2133.2002.48119.x</idno>
<idno type="url">https://api.istex.fr/document/47C5023827ABEF3A924BDE23BB2C4163CB89E9F0/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002093</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002093</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
<author><name sortKey="Baran, R" sort="Baran, R" uniqKey="Baran R" first="R." last="Baran">R. Baran</name>
<affiliation><mods:affiliation>Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: baran.r@club‐internet.fr</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint><biblScope unit="vol">147</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="180">180</biblScope>
<biblScope unit="page" to="195">195</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-07">2002-07</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>wiley</corpusName>
<keywords><teeft><json:string>dermatology</json:string>
<json:string>psoriasis</json:string>
<json:string>dermatol</json:string>
<json:string>dermatitis</json:string>
<json:string>puva</json:string>
<json:string>atopic</json:string>
<json:string>pemphigus</json:string>
<json:string>dermatologist</json:string>
<json:string>papuloerythroderma</json:string>
<json:string>british journal</json:string>
<json:string>british association</json:string>
<json:string>cyclosporin</json:string>
<json:string>atopic dermatitis</json:string>
<json:string>ivig</json:string>
<json:string>vasculitis</json:string>
<json:string>doubs</json:string>
<json:string>itraconazole</json:string>
<json:string>genital</json:string>
<json:string>ofuji</json:string>
<json:string>penile</json:string>
<json:string>corticosteroid</json:string>
<json:string>eczema</json:string>
<json:string>mmhg</json:string>
<json:string>eosinophil</json:string>
<json:string>immunoglobulin</json:string>
<json:string>intravenous</json:string>
<json:string>acitretin</json:string>
<json:string>lupus</json:string>
<json:string>psoriatic</json:string>
<json:string>node</json:string>
<json:string>lymphoma</json:string>
<json:string>hypertension</json:string>
<json:string>erythematosus</json:string>
<json:string>cutaneous</json:string>
<json:string>allergy</json:string>
<json:string>allergen</json:string>
<json:string>leucocytoclastic</json:string>
<json:string>acad dermatol</json:string>
<json:string>systemic lupus erythematosus</json:string>
<json:string>cell carcinoma</json:string>
<json:string>viral warts</json:string>
<json:string>serum levels</json:string>
<json:string>penile cancer</json:string>
<json:string>skin symptoms</json:string>
<json:string>linear nail growth</json:string>
<json:string>yellow nail syndrome</json:string>
<json:string>leucocytoclastic vasculitis</json:string>
<json:string>carcinoma</json:string>
<json:string>mite</json:string>
<json:string>pneumocystis carinii pneumonia</json:string>
<json:string>british skin foundation</json:string>
<json:string>psoriasis patients</json:string>
<json:string>cyclosporin treatment</json:string>
<json:string>antireticulin antibodies</json:string>
<json:string>intravenous immunoglobulin</json:string>
<json:string>nail growth</json:string>
<json:string>ofuji papuloerythroderma</json:string>
<json:string>lesion</json:string>
<json:string>nail</json:string>
<json:string>psoriatic subjects</json:string>
<json:string>adenosine deaminase deficiency</json:string>
<json:string>acta derm venereol</json:string>
<json:string>corticosteroid therapy</json:string>
<json:string>cancer study</json:string>
<json:string>thiol group</json:string>
<json:string>cancer registration</json:string>
<json:string>haut rhin</json:string>
<json:string>heart rate</json:string>
<json:string>coeliac disease</json:string>
<json:string>gluten intolerance</json:string>
<json:string>pulse rate</json:string>
<json:string>antigliadin antibodies</json:string>
<json:string>blood pressure</json:string>
<json:string>immunosuppressive drugs</json:string>
<json:string>pyoderma gangrenosum</json:string>
<json:string>further details</json:string>
<json:string>vascular biology</json:string>
<json:string>brinoid necrosis</json:string>
<json:string>careful monitoring</json:string>
<json:string>renal transplant</json:string>
<json:string>recalcitrant warts</json:string>
<json:string>skin folds</json:string>
<json:string>application forms</json:string>
<json:string>cutaneous vasculitis</json:string>
<json:string>lymph node</json:string>
<json:string>deck chair sign</json:string>
<json:string>severe childhood atopic dermatitis</json:string>
<json:string>tissue transglutaminase</json:string>
<json:string>oral acitretin</json:string>
<json:string>psoriatic patients</json:string>
<json:string>severe pneumonia</json:string>
<json:string>laboratory investigations</json:string>
<json:string>hyperkeratotic warts</json:string>
<json:string>adverse effects</json:string>
<json:string>rare event</json:string>
<json:string>dermatitis herpetiformis</json:string>
<json:string>clin dermatol</json:string>
<json:string>human virus</json:string>
<json:string>severe psoriasis</json:string>
<json:string>immunosorbent assay</json:string>
<json:string>duodenal stroma</json:string>
<json:string>skin disease</json:string>
<json:string>consecutive days</json:string>
<json:string>celiac disease</json:string>
<json:string>penile carcinoma</json:string>
<json:string>white cell count</json:string>
<json:string>sodium ethylmercuryl thiosalicylate</json:string>
<json:string>renal function</json:string>
<json:string>suprabasal cleavage</json:string>
<json:string>indirect immunoblotting</json:string>
<json:string>oral antifungal drugs</json:string>
<json:string>other patients</json:string>
<json:string>puva treatments</json:string>
<json:string>previous studies</json:string>
<json:string>topical corticosteroids</json:string>
<json:string>yellow nails</json:string>
<json:string>oral prednisolone</json:string>
<json:string>normal nails</json:string>
<json:string>parallelgroup comparison</json:string>
<json:string>toenail onychomycosis</json:string>
<json:string>dermatophyte onychomycosis</json:string>
<json:string>itraconazole pulse therapy</json:string>
<json:string>fondation rene touraine fellowships</json:string>
<json:string>house dust mite control measures</json:string>
<json:string>atopy patch test</json:string>
<json:string>annual incidence</json:string>
<json:string>radioallergosorbent test</json:string>
<json:string>placebocontrolled house dust mite control measures</json:string>
<json:string>adult patients</json:string>
<json:string>high dose exposure</json:string>
<json:string>national cancer institute</json:string>
<json:string>photochemotherapy study</json:string>
<json:string>main text</json:string>
<json:string>medical students</json:string>
<json:string>skin ageing</json:string>
<json:string>genital tumors</json:string>
<json:string>adenosine deaminase</json:string>
<json:string>grant applications</json:string>
<json:string>cancer registry</json:string>
<json:string>syndrome</json:string>
<json:string>lymph</json:string>
</teeft>
</keywords>
<author><json:item><name>R. Baran</name>
<affiliations><json:string>Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: baran.r@club‐internet.fr</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>BJD4811_9</json:string>
</articleId>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>letter</json:string>
</originalGenre>
<qualityIndicators><score>5.012</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>10194</pdfWordCount>
<pdfCharCount>65606</pdfCharCount>
<pdfPageCount>16</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
<genre><json:string>review-article</json:string>
</genre>
<host><title>British Journal of Dermatology</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1111/(ISSN)1365-2133</json:string>
</doi>
<issn><json:string>0007-0963</json:string>
</issn>
<eissn><json:string>1365-2133</json:string>
</eissn>
<publisherId><json:string>BJD</json:string>
</publisherId>
<volume>147</volume>
<issue>1</issue>
<pages><first>180</first>
<last>195</last>
<total>2</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>Correspondence</value>
</json:item>
</subject>
</host>
<categories><wos><json:string>science</json:string>
<json:string>dermatology</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>dermatology & venereal diseases</json:string>
</scienceMetrix>
</categories>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi><json:string>10.1046/j.1365-2133.2002.48119.x</json:string>
</doi>
<id>47C5023827ABEF3A924BDE23BB2C4163CB89E9F0</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/47C5023827ABEF3A924BDE23BB2C4163CB89E9F0/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/47C5023827ABEF3A924BDE23BB2C4163CB89E9F0/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/47C5023827ABEF3A924BDE23BB2C4163CB89E9F0/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
</titleStmt>
<publicationStmt><publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-07"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="review-article" source="letter" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
<author xml:id="author-0000"><persName><forename type="first">R.</forename>
<surname>Baran</surname>
</persName>
<affiliation>
Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: <address><country key="FR"></country>
</address>
</affiliation>
<email>baran.r@club‐internet.fr</email>
</author>
<idno type="istex">47C5023827ABEF3A924BDE23BB2C4163CB89E9F0</idno>
<idno type="DOI">10.1046/j.1365-2133.2002.48119.x</idno>
<idno type="unit">BJD4811_9</idno>
<idno type="toTypesetVersion">file:BJD.BJD4811_9.pdf</idno>
</analytic>
<monogr><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="pISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<idno type="book-DOI">10.1111/(ISSN)1365-2133</idno>
<idno type="book-part-DOI">10.1111/bjd.2002.147.issue-1</idno>
<idno type="product">BJD</idno>
<idno type="publisherDivision">ST</idno>
<imprint><biblScope unit="vol">147</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="180">180</biblScope>
<biblScope unit="page" to="195">195</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-07"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/47C5023827ABEF3A924BDE23BB2C4163CB89E9F0/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Science Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi>
<issn type="print">0007-0963</issn>
<issn type="electronic">1365-2133</issn>
<idGroup><id type="product" value="BJD"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup><title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="07001"><doi origin="wiley">10.1111/bjd.2002.147.issue-1</doi>
<numberingGroup><numbering type="journalVolume" number="147">147</numbering>
<numbering type="journalIssue" number="1">1</numbering>
</numberingGroup>
<coverDate startDate="2002-07">July 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="letter" position="0018000" status="forIssue"><doi origin="wiley">10.1046/j.1365-2133.2002.48119.x</doi>
<idGroup><id type="unit" value="BJD4811_9"></id>
</idGroup>
<countGroup><count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup><title type="articleCategory">Correspondence</title>
</titleGroup>
<eventGroup><event type="firstOnline" date="2002-07-03"></event>
<event type="publishedOnlineFinalForm" date="2002-07-03"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-08"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst" number="180">180</numbering>
<numbering type="pageLast" number="195">195</numbering>
</numberingGroup>
<linkGroup><link type="toTypesetVersion" href="file:BJD.BJD4811_9.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="9"></count>
<count type="wordTotal" number="1266"></count>
<count type="linksPubMed" number="0"></count>
<count type="linksCrossRef" number="0"></count>
</countGroup>
<titleGroup><title type="main">The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
<title type="shortAuthors">CORRESPONDENCE</title>
</titleGroup>
<creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1-9"><personName><givenNames>R.</givenNames>
<familyName>Baran</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="a1-9" countryCode="FR"><unparsedAffiliation>
Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: <email normalForm="baran.r@club-internet.fr">baran.r@club‐internet.fr</email>
</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>The new oral antifungal drugs in the treatment of the yellow nail syndrome</title>
</titleInfo>
<name type="personal"><namePart type="given">R.</namePart>
<namePart type="family">Baran</namePart>
<affiliation>Nail Disease Centre, 42 rue des Serbes, 06400 Cannes, France E‐mail: baran.r@club‐internet.fr</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="letter"></genre>
<originInfo><publisher>Blackwell Science Ltd</publisher>
<place><placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-07</dateIssued>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="references">9</extent>
<extent unit="words">1266</extent>
</physicalDescription>
<relatedItem type="host"><titleInfo><title>British Journal of Dermatology</title>
</titleInfo>
<genre type="journal">journal</genre>
<subject><genre>article-category</genre>
<topic>Correspondence</topic>
</subject>
<identifier type="ISSN">0007-0963</identifier>
<identifier type="eISSN">1365-2133</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-2133</identifier>
<identifier type="PublisherID">BJD</identifier>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>147</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>180</start>
<end>195</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">47C5023827ABEF3A924BDE23BB2C4163CB89E9F0</identifier>
<identifier type="DOI">10.1046/j.1365-2133.2002.48119.x</identifier>
<identifier type="ArticleID">BJD4811_9</identifier>
<recordInfo><recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Science Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002093 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002093 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:47C5023827ABEF3A924BDE23BB2C4163CB89E9F0 |texte= The new oral antifungal drugs in the treatment of the yellow nail syndrome }}
This area was generated with Dilib version V0.6.31. |